Sally P. Stabler * and Robert H. Allen. Metabolism. Clinical Chemistry 50: (2004) Endocrinology and
|
|
- Godwin Harrell
- 5 years ago
- Views:
Transcription
1 Clinical Chemistry 50: (2004) Endocrinology and Metabolism Quantification of Serum and Urinary S-Adenosylmethionine and S-Adenosylhomocysteine by Stable-Isotope- Dilution Liquid Chromatography Mass Spectrometry Sally P. Stabler * and Robert H. Allen Division of Hematology, Department of Medicine, University of Colorado Health Sciences Center, Denver, CO *Address correspondence to this author at: 4200 East 9th Ave., Box B170, Denver, CO Fax ; Sally.Stabler@UCHSC.edu. Received August 28, 2003; accepted November 11, Previously published online at DOI: /clinchem Background: We have developed an assay that uses stable-isotope-dilution liquid chromatography mass spectrometry to assess S-adenosylmethionine (SAM) and S-adenosylhomocysteine (SAH) in body fluids to investigate the relationship of these metabolites to hyperhomocysteinemia. Methods: Commercially obtained SAM (D 3 methyl) and 13 C 5 -SAH uniformly labeled in the adenosyl moiety, which was synthesized using S-adenosylhomocysteine hydrolase, were added to samples followed by perchloric acid protein precipitation, C 18 chromatography, and analysis by liquid chromatography mass spectrometry with quantification by comparison of the areas of internal standard and endogenous peaks. Results: Estimates of intraassay imprecision (CV) were 5% and 17% for SAM and SAH, respectively (n 10). SAM decreased and SAH increased in serum and plasma samples at both 4 C and room temperature over 80 h. SAM and SAH were unstable in samples stored longer than 2 years at 20 C. In 48 volunteers, the estimated reference intervals [from mean (2 SD) of log-transformed data] for serum SAM and SAH were and 8 26 nmol/l, respectively. Fractional excretion of SAM was higher than that of SAH, and the urinary SAM:SAH ratio was much higher than the serum or erythrocyte SAM:SAH ratios. Conclusions: Stable-isotope-dilution liquid chromatography mass spectrometry can be used to quantify SAM and SAH in biological fluids and tissues. Sample handling and storage must be stringently controlled for any epidemiologic or clinical use of such assays American Association for Clinical Chemistry Serum total homocysteine (thcy) 1 is increased in both vitamin B 12 and folate deficiency and is corrected by treatment with the appropriate vitamin(s) (1, 2). Patients with renal failure also have increased thcy (3, 4), which is partially responsive to high-dose vitamin therapy (4). Increased thcy has been associated with thrombosis and other vascular diseases (5), mortality from vascular diseases and other causes (6), and cognitive disorders (7). It is not completely evident, however, whether these deleterious effects are attributable to hyperhomocysteinemia or to the underlying vitamin deficiency, with the increased thcy simply being a marker for the deficiency condition. Abnormal methylation of crucial neurotransmitters, phospholipids, myelin, and/or other proteins has been a long-standing postulated explanation for the neurologic and cognitive disorders frequently seen in vitamin B 12 deficiency (7). This hypothesis has been based on the folate and B 12 -dependent conversion of homocysteine to methionine, which is the precursor for S-adenosylmethionine (SAM). SAM is the most important physiologic methylator (8). The product of the methylation, S-adenosylhomocysteine (SAH) is an inhibitor of many of these reactions (9). The ratio of SAM to SAH has been termed the methylation index, and it could be abnormal because of a decrease in SAM, an increase in SAH, or both. SAH is cleaved to homocysteine and adenosine by SAH 1 Nonstandard abbreviations: thcy, total homocysteine; SAM, S-adenosylmethionine; SAH, S-adenosylhomocysteine; LC/MS, liquid chromatography mass spectrometry; SIM, selected-ion monitoring; and Cbl, cobalamin. 365
2 366 Stabler and Allen: Serum SAM and SAH hydrolase, a reaction that, however, is favored in the reverse direction (10). It is thought that when homocysteine or adenosine increases, significant amounts of SAH would be formed in vivo. Experimental vitamin B 12 deficiency induced by nitrous oxide was reported to change the methylation ratio in brain and spinal cord as the result of a build up of SAH (11). However, there have been few data in humans about the relationships of thcy to SAH and SAM until recently because of problems inherent in measuring these metabolites in readily accessible body fluids, such as plasma, where they are present in nanomolar quantities. A HPLC assay had been reported for erythrocyte SAM and SAH, and it has been shown that SAH is increased in the erythrocytes of patients with renal failure (12, 13). More sensitive assays using HPLC (14 16) or, most recently, stable-isotopedilution tandem mass spectrometry (17) have shown significant correlations between thcy and SAH (16, 18, 19) as well as between creatinine and these metabolites (18, 19). We have shown that serum SAH was increased, and then decreased with vitamin B 12 therapy, in a pilot study of patients with severe megaloblastic anemia attributable to vitamin B 12 deficiency (20). We describe here a stable-isotope-dilution liquid chromatography mass spectrometry (LC/MS) method used to determine reference intervals for serum, urine, and erythrocytes and to study relationships of other metabolites and clinical variables with SAH and SAM. Materials and Methods U- 13 C 5 -Adenosine (98%) was obtained from Cambridge Isotope Laboratories, Inc. D 3 -S-Adenosyl-l-methionine, tri(p-toluenesulfonate) salt (99 atom % D; 85% chemical purity; D 3 -SAM) was obtained from C/D/N Isotopes. d,l-homocysteine and S-adenosyl-l-homocysteine hydrolase from rabbit erythrocytes were obtained from Sigma, and Tris base was obtained from Sigma-Aldrich. C-18 YMC-gel, ODS-A (12 nm I-230/70 mesh) was obtained from YMC Co., Ltd. HPLC-grade methanol and other solvents were used throughout. Heptafluorobutyric acid (99%) was obtained from Aldrich Chemical Company. methods Synthesis of S-adenosyl-U- 13 C 5 -homocysteine ( 13 C 5 -SAH). SAH containing five 13 C molecules in the adenosyl moiety was synthesized by incubating 20 moles of U-( 13 C 5 )- adenosine with d,l-homocysteine (100 moles) in the presence of 20 nmoles of Tris base, 77 moles of dithiothreitol, and 2 U of SAH hydrolase in a total volume of ml at 35 C for 24 h. An additional 2 U of SAH hydrolase were added after 3 h. The reaction mixture was split and then applied to two individual columns ( cm) prepared with 20 m polyethylene frits and 200 mg of YMC-gel that had been prewashed with 3 ml of methanol and three 3-mL volumes of H 2 O. The loaded columns were washed four times with three 1-mL volumes of H 2 O, and the run-through was collected. The water wash was followed by three 1-mL washes of 750 ml/l methanol, and the run-through was collected. The aliquots were assayed for SAH as described below. The aliquots with the greatest concentrations of SAH (second water wash through first methanol wash) were pooled. The labeled SAH was quantified by assaying it with known quantities of SAH. The pooled material was aliquoted and stored frozen at 80 C. The recovery of SAH was 28% compared with the starting amount of labeled adenosine. A combination internal standard mixture was prepared by combining the commercially obtained D 3 - SAM and the synthesized 13 C 5 -SAH to give final concentrations of 40 mol/l D 3 -SAM and 20 mol/l 13 C 5 -SAH in 1 mmol/l HCl. The internal standard was used at this concentration for testing whole blood or tissue samples and was diluted 1:5 in H 2 O for serum, urine, or plasma. Sample preparation. Diluted internal standard containing 0.4 nmol of D 3 -SAM and 0.2 nmol of 13 C 5 -SAH was added to 0.5 ml of plasma, serum, or cerebrospinal fluid or to 50 L of urine; 1.0 ml of H 2 O (or 1.5 ml of tissue culture medium) and ml of 100 g/l perchloric acid solution in H 2 O were then added, followed by 5 L of 99% pure heptafluorobutyric acid. After mixing, the tubes were centrifuged for 30 min at g. The supernatant was loaded on YMC gel columns (200 mg of gel; cm; fitted with a frit) that were prewashed once with 3 ml of acetonitrile, four times with 3 ml of H 2 O, and once with 3mLofH 2 O containing 10 mmol/l heptafluorobutyric acid NH 4 OH, ph 3.2. The loaded columns were then washed four times with 3 ml of the heptafluorobutyric acid solution and were eluted with 1 ml of 750 ml/l acetonitrile in H 2 O. The eluates were taken to dryness in a Savant vacuum centrifuge, dissolved in 50 L ofh 2 O, and analyzed by LC/MS. Fresh or frozen whole blood was mixed thoroughly. We then added 50 L of the concentrated internal standard mixture and 1 ml of H 2 O, after which we added ml of 100 g/l perchloric acid with vortex-mixing. Samples of tissues such as liver or lung ( mg wet weight) were homogenized in 1 5 mlofh 2 O with 50 L of the concentrated internal standard in a VirTishear (VirTis Co.) at approximately half speed for 15 s, followed by homogenization twice with ml of 100 g/l perchloric acid for 15 s on high speed. Prepared samples were frozen at 80 C or assayed fresh by the method described above for plasma or serum after centrifugation for 30 min at g. Instrumentation and analysis. Analysis by LC/MS was performed with a Hewlett Packard Series 1100 MSD equipped with a Hewlett Packard Kayak XM Gap 600 Chem Station. Analysis was performed on an Aquasil C 18 column [ mm (i.d.); particle size, 5 m; Thermo Hypersil-Keystone; Keystone Scientific, Inc.]. Starting conditions for analysis included a column temperature of
3 Clinical Chemistry 50, No. 2, C, and sample tray temperature of 6 C, The instrument was operated in positive ion atmospheric pressure ionization-electrospray mode with flow at 0.3 ml/min. The following settings were used: capillary voltage, 3000 V; nitrogen drying gas temperature, 350 C; nitrogen drying gas flow, 10 L/min; nebulizer pressure set point, 50 psi. The instrument was set for high-resolution selected-ion monitoring (SIM) with gain at 4 and fragmenter at 70. The solvents for LC analysis were as follows: solvent A, 100% H 2 O; solvent B, 100 ml/l H 2 O 900 ml/l methanol. Both solvents A and B contained 10 mmol/l heptafluorobutyric acid NH 4 OH, ph 3.2. The injection volume was L. Initial conditions were 99.9% A 0.1% B for 1.5 min, then a linear gradient up to 100% B over 14 min and holding for 35 min. The column was equilibrated at the initial conditions for 20 min between injections. The MSD start time was 7 min, and stop time was 15 min. Quantification. The protonated molecular ions for SAM and SAH were monitored. Unlabeled SAH (endogenous) was monitored at m/z 385, and the internal standard was monitored at m/z 390. The unlabeled SAM was monitored at m/z 399 and the labeled SAM at m/z 402. The stableisotope-enriched adenosine used in the synthesis of SAH was only 98% pure; thus the labeled SAH contained ion peaks at both m/z 390 (98%) and m/z 385 (2%). The internal standard mixture was run as a blank test mixture in each assay, and the peak area monitored at m/z 385 in the internal standard was then used to adjust the values in the samples. No correction was needed for the SAM internal standard because there was 0.1% peak area of m/z 399 compared with the peak area at m/z 402. Quantification was achieved by comparing the ratio of the peak areas of the endogenous m/z 385 or m/z 399 peaks with the peak areas of the respective internal standards, m/z 390 and m/z 402, and multiplying by the known quantity of internal standard added with further adjustments for the volume of sample added. clinical samples The collection of samples by phlebotomy from healthy individuals was approved by the University of Colorado Institutional Review Board after informed consent. Samples were obtained from nonfasting seated individuals from antecubital veins. In general, venous blood samples were allowed to clot for 15 min, and then iced at 4 C and centrifuged to remove serum or plasma immediately. Serum and plasma were stored frozen at either 20 or 80 C. Urine was fresh frozen. Venous blood was drawn into tubes suitable for serum and into EDTA- or heparincontaining tubes for plasma preparation at the same phlebotomy session to test differences. Serum, plasma, and urine was stored in polypropylene tubes for 2, 4, 24, and 80 h at either room temperature (21 C) or 4 C ina cold room. Total homocysteine, cystathionine, methylmalonic acid, methionine, and cysteine were analyzed by previously developed stable-isotope-dilution capillary gas chromatography mass spectrometry methods (21, 22). The central 95% intervals for some of these metabolites were determined previously from samples from 60 blood donors and were as follows; homocysteine, mol/l; methylmalonic acid, nmol/l (23, 24). Serum and urinary creatinine were measured in the University of Colorado Hospital Clinical Laboratory. Serum cobalamin (Cbl) and serum folate were measured by the DPC, Dual Count Solid Phase No Boil Assay (Diagnostic Products Corp.). The hematocrit was determined by centrifugation of whole blood in microtubes. The following equation was used to calculate the fractional excretion of SAM or SAH: SAM or SAH creatinine clearance ratio [urinary SAM (nmol/l) 1/urinary creatinine mol/l]/[serum SAM (nmol/l) 1/serum creatinine ( mol/l)] 100. statistical evaluations Most of the measured variables had a distribution skewed toward higher values. Log-transformed values were therefore used to estimate the central 95% interval as the mean 2 SD. The Spearman correlation coefficient ( ) was used to test bivariate associations between variables. For multivariate analysis of factors predicting serum SAM, SAH, and thcy, a stepwise multiple linear regression model was used. The level of significance for all analysis was The differences in means for continuous variables across two categories were evaluated with a t-test and the Levene test for equality of variances. The analyses were performed with SPSS Base software, Ver (SPSS, Inc.). Results Shown in Fig. 1 are chromatograms of a sample of normal human serum that had been prepared as described in Materials and Methods and subjected to LC/MS as described above. When serum was prepared and analyzed without added internal standard, there were no significant peaks interfering with the internal standard quantification (data not shown). The sample preparation, including evaporative centrifugation, took 5 h, and LC/MS analysis took 1 h/sample; therefore, 40 samples were routinely quantified over a 48-h interval. Separated serum, plasma, or urine samples (n 2 5) were incubated for 2 80 h at 4 C and room temperature to test the stability of the metabolites, as shown in Table 1. After 80 h at room temperature, there was virtually no detectable SAM in serum, and the SAH had increased 350%. There was a 20% difference in SAM and SAH values in serum vs heparin- or EDTA-plasma that was drawn at the same phlebotomy session from the same individual. Freezing and thawing either the serum or heparin-plasma three times did not significantly change the SAM or SAH concentrations.
4 368 Stabler and Allen: Serum SAM and SAH assay precision and detection limit One healthy control was phlebotomized four times over 9 months; the SAM concentration ranged from 83 to 100 nmol/l and SAH from 10 to 22 nmol/l without any trend. Serum from healthy controls was aliquoted and assayed in each day s assay. Table 2 shows the interassay CV determined for samples from three healthy controls assayed over time. The intraassay CV is also shown in Table 2. Samples stored at 20 C for 2 years had decreases in SAM of at least 50% and increases in SAH of %. The sensitivity of the assay was assessed by assaying volumes of serum from 25 to 500 L. The SAM result was only 1% different with 250 L of serum compared with 500 L, which is within the intraassay variability. However, the result with 100 L varied by 16%, 50 L by 2%, and 25 L by 12%, suggesting that values obtained from serum volumes 250 L were unreliable. The SAH value obtained by assaying 250 Lof serum was 31% lower than that obtained with 500 L of serum, and SAH was not quantifiable in smaller amounts of serum. Therefore, the limit of quantification for either SAM or SAH is 5 pmol in a serum sample. We recovered 96% and 94% of the SAH and SAM, respectively, when we added enough unlabeled material to increase the serum values by 40 and 75 nmol/l. We added unlabeled SAH and SAM to the autosampler vials immediately before injection on the LC/MS system or before vacuum evaporative centrifugation and compared the peak areas with those obtained with added material at the start of the assay. The peak areas representing SAH for the three above conditions were within 3% of each other. In contrast, the peak area for SAM added at the beginning of the procedure was only 55% and 56% of the peak areas obtained when the unlabeled SAM was added immediately before injection on the LC/MS system or before vacuum evaporative centrifugation, respectively. Fig. 1. Chromatograms for normal human serum prepared as described in Materials and Methods. The top two panels show the peaks for endogenous SAH monitored at m/z 385 by SIM and the internal standard peak monitored at m/z 390, eluting at 10.3 min. The bottom two panels show the endogenous SAM peak monitored at m/z 399 and internal standard peak monitored at m/z 402, eluting at 10.4 min. estimation of human reference intervals Serum, urine, and whole blood were collected from 48 healthy controls [mean (SD) age, 38.5 (11.2) years; range, years; 44% female]. There were 39 whites (6 white Hispanics), 1 Native American Hispanic, 3 African Americans and 5 Asians. The occupations of the controls were diverse. Multivitamins were consumed at least weekly by 40% of the group. The log-normalized mean and estimated reference intervals for SAM, SAH, and the SAM: SAH ratio and some of the other metabolites are shown in Table 3. The mean thcy, methylmalonic acid, and creatinine concentrations were within the appropriate reference intervals, as shown in Table 3. The mean (SD) serum Cbl was 412 (493) pmol/l, and serum folate was 65.3 (26.4) nmol/l. The mean hematocrit was 46%, a value consistent with the altitude of Denver, CO. There was no significant difference in age between the males and females in the healthy controls. As expected, serum creatinine, hematocrit, and thcy were significantly higher in males than in females. Mean serum SAM
5 Clinical Chemistry 50, No. 2, Table 1. Mean (SD) change from baseline a of SAM and SAH in samples incubated in various conditions before analysis. Time of incubation 2h b 4h c 24 h d 80 h e Sample Temperature SAM SAH SAM SAH SAM SAH SAM SAH Serum or plasma 4 C 0 (14)% 10 (9)% 3 (9)% 19 (6)% 4 (7)% 33 (26)% 16 (2)% 76 (69)% Room temperature 1 (7)% 27 (13)% 12 (9)% 32 (22)% 41 (16)% 185 (88)% 97 (8)% 350 (218)% Urine 4 C 0 (3)% 37 (55)% 4 (2)% 1 (21)% Room temperature 7 (20)% 10 (11)% 12 (34)% 25 (16)% a SAM and SAH are expressed as the percentages of the concentrations in the individual baseline samples, which were stored at 80 C until the assay and thawed in ice. A negative sign denotes loss in value. Initial concentrations were nmol/l for SAM and 8 22 nmol/l for SAH in serum or plasma. b n 3 for plasma and serum; n 2 for urine. c n 4 for plasma and serum; n 2 for urine. d n 5 for plasma and serum at room temperature; n 4 for plasma and serum at 4 C; n 2 for urine. e n 3 for plasma and serum at room temperature; n 2 for plasma and serum at 4 C. concentrations were 119 and 102 nmol/l in males and females (P 0.025), and serum SAH was also higher, 17 vs 13 nmol/l (P 0.001). The SAM:SAH ratio trended to be higher in females (8.3) than in males (7.2; P 0.056). The red cell SAM was higher in males, 3.9 vs 3.4 mol/l (P 0.001), although red cell SAH and the SAM:SAH ratio were not different. The fractional excretion of SAM and SAH and the serum Cbl and serum folate values were not different between males and females. The use of multivitamins did not produce any differences in the concentrations of SAM, SAH, vitamins, or the other methionine metabolites. We calculated the mean fractional excretion of SAM and SAH compared with that of creatinine and obtained values of 93% for SAM and 39% for SAH, which may explain the high ratio of SAM to SAH in urine. In contrast, the fractional excretion of thcy and methionine in this group of healthy controls was 0.37% and 0.21%, respectively. Samples were obtained from two individuals on regular hemodialysis before their dialysis session, and the serum SAM values were 177 and 286 nmol/l. The serum SAH values were 244 and 402 nmol/l in the same patients; thus, the SAM:SAH ratios were 0.73 and 0.71, respectively. Values for rat liver and rat lung are shown in Table 4. The rat lungs were perfused with saline to prevent blood contamination and had an extremely high SAM:SAH ratio of 84. Table 2. Inter- and intraassay CV for serum samples. Mean CV, % (nmol/l) Individuals n a Time b SAM SAH Interassay months 5.7 (102) 23 (19) months 11 (89) 16 (13) months 7.4 (108) 22 (11) Intraassay day 5.2 (109) 17 (9) a Number of assayed samples. b Time interval during which samples were assayed. correlations between variables The Spearman correlation coefficients and P values for SAM, SAH, and the related metabolites are shown in Table 5. Red blood cell SAM and SAH did not correlate with serum or urinary SAM and SAH and thus are not shown in Table 5. Serum creatinine was strongly correlated with serum SAH, trended with serum SAM, and was strongly inversely correlated with the serum SAM: SAH ratio. Serum creatinine was also strongly correlated with urinary SAH and inversely correlated with the urinary SAM:SAH ratio but did not correlate with the urinary SAM value. The serum SAM and SAH values were directly correlated with their concentrations in urine, and the serum SAM:SAH ratio was inversely correlated to the urinary SAH but not the urinary SAM concentration. The serum and urinary SAM:SAH ratios were directly correlated. Serum thcy was weakly correlated with serum SAH; inversely correlated with serum SAM:SAH ratio; and correlated with serum folate. Serum Table 3. Geometric mean and estimated central 95% values from 48 healthy controls. Mean Estimated central 95% a Serum SAM, nmol/l SAH, nmol/l SAM:SAH ratio Red blood cells SAM, mol/l SAH, mol/l SAM:SAH ratio Urine SAM, mol/l SAH, mol/l SAM:SAH ratio Serum thcy, mol/l Methylmalonic acid, nmol/l Creatinine, mol/l a Central 95% interval cutpoints were estimated as the mean 2SDofthe log-transformed results.
6 370 Stabler and Allen: Serum SAM and SAH Table 4. Mean (SE) values for SAM, SAH, and SAM:SAH ratio in rat liver and lung. SAM SAH SAM: SAH ratio Rat liver, nmol/g wet 72 (3) 20 (1) 3.6 (0.3) weight (n 3) Rat lung, a nmol/mg protein (n 3) 1443 (32) 17 (0.6) 84 (2.0) a Perfused to eliminate blood contamination of tissue and expressed per mg of protein because wet weight was altered by perfusion. Cbl and folate were directly correlated, but neither vitamin correlated with the serum SAM or SAH values, although the serum SAM:SAH ratio was directly correlated with serum folate. Serum creatinine was correlated with serum methionine, total cysteine, N-methylglycine, and N,N-dimethylglycine, but not serum cystathionine. Serum cystathionine (not on Table 5) directly correlated with SAH (Spearman 0.39; P 0.006), trended with serum SAM ( 0.28; P 0.056), and correlated with serum thcy ( 0.399, P 0.005). Correlations between the other sulfur-containing amino acids and SAM and SAH were corrected for serum creatinine because of the strong influence of serum creatinine on the values. After we controlled for creatinine, thcy was no longer correlated with SAH and was now inversely correlated with SAM. N,N-Dimethylglycine was positively correlated with both SAM and SAH, whereas N-methylglycine was not. Methionine showed a trend with both SAM and SAH, and cystathionine trended with SAH. N-Methylglycine remained directly correlated with methionine, and thcy correlated directly with cysteine and indirectly with folate after correction for serum creatinine. A linear regression analysis with stepwise entering of variables showed that both serum SAH and urinary SAM were predictors of serum SAM. Predictors of serum SAH were serum creatinine and serum SAM, and predictors of thcy were serum creatinine and serum folate. Discussion We have developed a sensitive and specific assay for SAH and SAM in body fluids and biological materials that uses LC/MS and stable-isotope-dilution quantification meth- Table 5. Spearman correlation between selected variables. Serum Urine Serum Cr a SAM SAH SAM:SAH SAM SAH SAM:SAH thcy MMA Cbl folate Serum Cr P Serum SAM P Serum SAH P Serum SAM:SAH P Urinary SAM P Urinary SAH P Urinary SAM:SAH P Serum thcy P Serum MMA P Serum Cbl 0.31 P a Cr, creatinine; MMA, methylmalonic acid.
7 Clinical Chemistry 50, No. 2, ods. We used a negatively charged ion, heptafluorobutyric acid, on the C 18 column during sample clean-up and in the solutions for HPLC as a counter ion to retain SAM because it is volatile and well suited to LC/MS. The advantages of our method are that quantification is achieved with stable-isotope-labeled SAM and SAH as internal standards, which corrects for variations in recovery from sample to sample. Our assay is sensitive enough to quantify SAH in 0.5 ml of serum, but because normal serum SAH is on the order of nmol/l, our assay is close to the detection limit and the CV for SAH is greater than that for SAM. Several methods that are suitable for determining values in plasma, serum, or cerebrospinal fluid have been reported, including HPLC with fluorescence detection (15), HPLC with electrochemical detection (16), and a method that uses stable-isotope-dilution tandem mass spectrometry (17). Our values for serum SAM in controls were very similar to the values given for the previously reported stable-isotope-dilution method (17) and a corrected value for a HPLC method with coulometric electrochemical detection (16). Other HPLC methods gave higher (15) or lower (14) values than ours. Our mean SAH concentration in controls was lower than any of the other methods; thus our SAM:SAH ratio was higher than in the previous reports. Urinary SAM and SAH concentrations were roughly 100- and 30-fold higher than in serum, values similar to those in a previous report (23). We calculated a fractional excretion of SAM compared with creatinine, which was close to 100%, and also found that the SAM:SAH ratio in urine is much higher than in serum or red blood cells. These findings suggest that most SAM released into the bloodstream is probably excreted in the urine. The fractional excretion of SAH is less ( 40%), but it would be expected that renal insufficiency would have a major impact on excretion of both of these metabolites. The relationships between renal status and SAM and SAH are also complicated because the formation of creatine (precursor of creatinine) requires a SAM-dependent methylation, which is an important user of SAM (8). The SAM and SAH in serum vs urine should also be studied in populations with renal insufficiency because the decreased excretion of SAM relative to SAH in renal failure might impact the serum SAM:SAH ratio. Although increases in thcy seem to be a risk factor for vascular disease, the underlying pathophysiology has not been adequately explained. There have been recent reports that increased SAH (18, 19, 24), associated in some reports with DNA hypomethylation (18, 25), is present in populations with vascular disease. However, the role of poor renal status in increasing SAH and decreasing the SAM:SAH ratio has not been adequately explored in these populations. Our findings demonstrate that case control studies should examine renal status and gender as potential confounders of the relationship of SAM and SAH to vascular disease or vitamin status. We found that the serum SAM:SAH ratio was directly correlated with serum folate in our population, in contrast to a recent investigation (26). However, the earlier report (26) studied an elderly population, who clearly would have poorer renal function than the current group of healthy volunteers. We have found increased SAH and decreased SAM:SAH ratio in Brazilian individuals with severe Cbl-deficient megaloblastic anemia. The increased SAH corrected with Cbl therapy except in one individual with renal insufficiency (20). We also found a strong influence of renal status on response of increased thcy and SAH to vitamin therapy in a study of seniors (27). Therefore, the diagnostic utility of increased SAH in detecting Cbl or folate deficiency may be restricted to individuals with normal renal excretion of these metabolites. In addition, it may not be possible to infer the hepatic or other tissue SAM:SAH ratios from the serum values. We studied healthy individuals in the US in the postfolate food fortification era, 40% of whom also took vitamin supplements. Therefore, one limitation of our study is that the reference intervals were obtained in persons with high folate status. It will be of interest to determine whether populations with poorer folate status have higher SAH concentrations and lower SAM:SAH ratios. Measurements of SAM and SAH are of great interest in populations with neurologic or vascular disease (19, 25); when assessing the possible effects of drugs, such as levodopa and high-dose niacin; or in nutritional studies. We therefore examined conditions of sample handling and storage because the ability to quantify these metabolites in archived samples would be an obvious advantage. There are marked changes in the concentrations of SAM and SAH after exposure of samples to room temperature or prolonged frozen storage, which would impact the utility of archived or transported samples. The conditions for thawing of samples and benchtop storage during their preparation will need to be uniform. One advantage of our isotope-dilution method is that the loss of the expected peak area of the internal standard may alert the investigator to problems developing during sample preparation. It is possible that some of the post vivo sampleholding conditions are responsible for the differences in normal SAM and SAH concentrations that are reported in the literature. It will be crucial to know the storage history of clinical samples before relying on the measured SAM: SAH ratio as a true measure of the methylation index in vivo. This research was supported in part by National Institute on Aging Grant AG (to S.P.S.). Expert technical assistance was provided by Bev Raab and Carla Ray. Expert assistance in preparing the manuscript was provided by Theresa Martinez.
8 372 Stabler and Allen: Serum SAM and SAH References 1. Stabler SP, Marcell PD, Podell ER, Savage DG, Lindenbaum J, Allen RH. Quantitation of total homocysteine, total cysteine, and methionine in normal serum using capillary gas chromatographymass spectrometry. Anal Biochem 1987;162: Savage DG, Lindenbaum J, Stabler SP, Allen RH. Sensitivity of serum methylmalonic acid and total homocysteine determinations for diagnosing cobalamin and folate deficiency. Am J Med 1994; 96: Soria C, Chadefaux B, Coude M Gaillard O, Kamoun P. Concentrations of total homocysteine in plasma in chronic renal failure [Technical Brief]. Clin Chem 1990;36: Bostom AG, Lathrop L. Hyperhomocysteinemia in end stage renal disease: prevalence, etiology, and potential relationship to arteriosclerotic outcomes. Kidney Int 1997;52: Ueland PM, Refsum H. Review article: plasma homocysteine, a risk factor for vascular disease, plasma levels in health, disease, and drug therapy. J Lab Clin Med 1989;114: Vollset SE, Refsum H, Tverdal A, Nygard O, Nordrehaug JE, Tell GS, et al. Plasma total homocysteine and cardiovascular and noncardiovascular mortality: the Hordaland Homocysteine Study. Am J Clin Nutr 2001;74: Weir DG, Scott JM. The biochemical basis of the neuropathy in cobalamin deficiency. Baillieres Clin Haematol 1995;8: Mudd SH, Levy HL, Svovby F. Disorders of transsulfurations. In: Scriver CR, Beaudet AL, Sly WS, Valle D, eds. The metabolic and molecular bases of inherited disease, 7th ed. New York: McGraw- Hill, 1995: Finkelstein JD, Kyle WE, Harris BJ. Methionine metabolism in mammals: regulatory effects of S-adenosylhomocysteine. Arch Biochem Biophys 1974;165: De la Haba G, Cantoni GL. The enzymatic synthesis of S-adenosyl- L-homocysteine from adenosine and homocysteine. J Biol Chem 1959;234: Molloy AM, Orsi B, Kennedy DG, Kennedy S, Weir DG, Scott JM. The relationship between the activity of methionine synthase and the ratio of S-adenosylmethionine to S-adenosylhomocysteine in the brain and other tissues of the pig. Biochem Pharmacol 1992;44: Perna AF, Ingrosso D, Zappia V, Galletti P, Capasso G, De Santo NG. Enzymatic methyl esterification of erythrocyte membrane proteins is impaired in chronic renal failure. Evidence for high levels of the natural inhibitor S-adenosylhomocysteine. J Clin Invest 1993;91: Fu W, Dudman NP, Perry MA, Young K, Wang XL. Interrelations between plasma homocysteine and intracellular S-adenosylhomocysteine. Biochem Biophys Res Commun 2000;271: Loehrer FM, Haefeli WE, Angst CP, Browne G, Frick G, Fowler B. Effect of methionine loading on 5-adenosylmethionine and S- adenosylhomocysteine in plasma of healthy humans. Clin Sci 1996;91: Capdevila A, Wagner C. Measurement of plasma S-adenosylmethionine and S-adenosylhomocysteine as their fluorescent isoindoles. Anal Biochem 1998;264: Melnyk S, Pogribna M, Pogribny IP, Yi P, James SJ. Measurement of plasma and intracellular S-adenosylmethionine and S-adenosylhomocysteine utilizing coulometric electrochemical detection: alterations with plasma homocysteine and pyridoxal 5 -phosphate concentrations [Erratum published in Clin Chem 2001;47:612]. Clin Chem 2000;46: Struys EA, Jansen EE, de Meer K, Jakobs C. Determination of S-adenosylmethionine and S-adenosylhomocysteine in plasma and cerebrospinal fluid by stable isotope dilution tandem mass spectrometry. Clin Chem 2000;46: Yi P, Melnyk S, Pogribna M, Pogribny IP, Hine RJ, James SJ. Increase in plasma homocysteine associated with parallel increases in plasma S-adenosylhomocysteine and lymphocyte DNA hypomethylation. J Biol Chem 2000;275: Kerins DM, Koury MJ, Capdevila A, Rana S, Wagner C. Plasma S-adenosylhomocysteine is a more sensitive indicator of cardiovascular disease than plasma homocysteine. Am J Clin Nutr 2001;74: Guerra-Shinohara EM, Morita OE, Pagliusi RA, Blaia-D Avila VL, Allen RH, Stabler SP. Elevation of serum S-adenosylhomocysteine in severe cobalamin deficient megaloblastic anemia [Abstract]. Blood 2001;98:13a. 21. Stabler SP, Lindenbaum J, Savage DG, Allen RH. Elevation of serum cystathionine levels in patients with cobalamin and folate deficiency. Blood 1993;81: Allen, RH, Stabler SP, Savage DG, Lindenbaum J. Elevation of 2-methycitric acid I and II levels in serum, urine, and cerebrospinal fluid of patients with cobalamin deficiency. Metabolism 1993;42: Delabar U, Kloor D, Luippold G, Muhlbauer B. Simultaneous determination of adenosine, S-adenosylhomocysteine and S-adenosylmethionine in biological samples using solid-phase extraction and high performance liquid chromatography. J Chromatogr B Biomed Sci Appl 1999;724: Loehrer FMT, Angst CP, Brunner FP, Haefeli WE, Fowler B. Evidence for disturbed S-adenosylmethionine: S-adenosylhomocysteine ratio in patients with end stage renal failure: a cause for disturbed methylation reactions? Nephrol Dial Transplant 1998; 13: Castro R, Rivera I, Struys EA, Jansen EEW, Ravasco P, Camilo ME, et al. Increased homocysteine and S-adenosylhomocysteine concentrations and DNA hypomethylation in vascular disease. Clin Chem 2003;49: Becker A, Smulders YM, Teerlink T, Struys EA, de Meer K, Kostense PJ, et al. S-Adenosylhomocysteine and the ratio of S-adenosylmethionine to S-adenosylhomocysteine are not related to folate, cobalamin and vitamin B 6 concentrations. Eur J Clin Invest 2003;33: Stabler SP, Allen RH, Dolce ET, Hawthorne NA, Johnson MA. Response of elevated serum S-adenosylhomocysteine and total homocysteine to high dose oral cobalamin [Abstract]. Blood 2002;100:227a.
Determination of β2-agonists in Pork Using Agilent SampliQ SCX Solid-Phase Extraction Cartridges and Liquid Chromatography-Tandem Mass Spectrometry
Determination of β2-agonists in Pork Using Agilent SampliQ SCX Solid-Phase Extraction Cartridges and Liquid Chromatography-Tandem Mass Spectrometry Application Note Food Safety Authors Chenhao Zhai Agilent
More informationDetermination of 6-Chloropicolinic Acid (6-CPA) in Crops by Liquid Chromatography with Tandem Mass Spectrometry Detection. EPL-BAS Method No.
Page 1 of 10 Determination of 6-Chloropicolinic Acid (6-CPA) in Crops by Liquid Chromatography with Tandem Mass Spectrometry Detection EPL-BAS Method No. 205G881B Method Summary: Residues of 6-CPA are
More informationDetermination of Tetracyclines in Chicken by Solid-Phase Extraction and High-Performance Liquid Chromatography
Determination of Tetracyclines in Chicken by Solid-Phase Extraction and High-Performance Liquid Chromatography Application ote Food Safety Authors Chen-Hao Zhai and Yun Zou Agilent Technologies Co. Ltd.
More informationEuropean Journal of Clinical Investigation (2003) 33, VU University Medical Center, Amsterdam, the Netherlands
European Journal of Clinical Investigation (2003) 33, 17 25 Blackwell Science, Ltd S-adenosylhomocysteine and the ratio of S-adenosylmethionine to S-adenosylhomocysteine are not related to folate, cobalamin
More informationA Robustness Study for the Agilent 6470 LC-MS/MS Mass Spectrometer
A Robustness Study for the Agilent 7 LC-MS/MS Mass Spectrometer Application Note Clinical Research Authors Linda Côté, Siji Joseph, Sreelakshmy Menon, and Kevin McCann Agilent Technologies, Inc. Abstract
More informationUltra Performance Liquid Chromatography Coupled to Orthogonal Quadrupole TOF MS(MS) for Metabolite Identification
22 SEPARATION SCIENCE REDEFINED MAY 2005 Ultra Performance Liquid Chromatography Coupled to Orthogonal Quadrupole TOF MS(MS) for Metabolite Identification In the drug discovery process the detection and
More informationApplication Note. Author. Abstract. Introduction. Food Safety
Determination of β2-agonists in Pork with SPE eanup and LC-MS/MS Detection Using Agilent BondElut PCX Solid-Phase Extraction Cartridges, Agilent Poroshell 120 column and Liquid Chromatography-Tandem Mass
More information!!"#$%&'#()*+,-).(&"/+0&'12'
LAB #: Sample Report PATIENT: Sample Patient ID: SEX: Female DOB: 01/01/1985 AGE: 33 CLIENT #: 12345 DOCTOR: Sample Doctor Doctors Data Inc 3755 Illinois Ave St. Charles, IL 60174 U.S.A.!!"#$%&'#()*+,-).(&"/+0&'12'
More informationDetection of Cotinine and 3- hydroxycotine in Smokers Urine
Detection of Cotinine and 3- hydroxycotine in Smokers Urine Behavioural and Situational Research Group School of Medicine, University of Tasmania Version number: 2 Effective date: 01/12/2015 Review due:
More informationAnalysis of anti-epileptic drugs in human serum using an Agilent Ultivo LC/TQ
Application Note Clinical Research Analysis of anti-epileptic drugs in human serum using an Agilent Ultivo LC/TQ Authors Jennifer Hitchcock 1, Lauren Frick 2, Peter Stone 1, and Vaughn Miller 2 1 Agilent
More informationAuthor. Introduction. Abstract
Simultaneous Measurement of Sirolimus and Tacrolimus Concentrations in Blood by Semi-Automated Extraction and Liquid Chromatography-Electrospray Ionization Mass Spectrometry Application Author Gary L.
More informationAuthors. Abstract. Introduction. Environmental
Determination of Ultratrace Amitrol in Water Samples by in situ Derivatization-Solid Phase Extraction-Liquid Chromatography-Mass Selective Detector Application Environmental Authors Gerd Vanhoenacker,
More informationMeasuring Lipid Composition LC-MS/MS
Project: Measuring Lipid Composition LC-MS/MS Verification of expected lipid composition in nanomedical controlled release systems by liquid chromatography tandem mass spectrometry AUTHORED BY: DATE: Sven
More informationRobust extraction, separation, and quantitation of structural isomer steroids from human plasma by SPE-UHPLC-MS/MS
TECHNICAL NOTE 21882 Robust extraction, separation, and quantitation of structural isomer steroids human plasma by SPE-UHPLC-MS/MS Authors Jon Bardsley 1, Kean Woodmansey 1, and Stacy Tremintin 2 1 Thermo
More informationVitamin D Metabolite Analysis in Biological Samples Using Agilent Captiva EMR Lipid
Vitamin D Metabolite Analysis in Biological Samples Using Agilent Captiva EMR Lipid Application Note Clinical Research Authors Derick Lucas and Limian Zhao Agilent Technologies, Inc. Abstract Lipids from
More informationDienes Derivatization MaxSpec Kit
Dienes Derivatization MaxSpec Kit Item No. 601510 www.caymanchem.com Customer Service 800.364.9897 Technical Support 888.526.5351 1180 E. Ellsworth Rd Ann Arbor, MI USA TABLE OF CONTENTS GENERAL INFORMATION
More informationOxalate (urine, plasma)
Oxalate (urine, plasma) 1 Name and description of analyte 1.1 Name of analyte Oxalate 1.2 Alternative names 1.3 NLMC code To follow 1.4. Function of analyte Oxalate is a metabolic end product primarily
More informationEdgar Naegele. Abstract
Simultaneous determination of metabolic stability and identification of buspirone metabolites using multiple column fast LC/TOF mass spectrometry Application ote Edgar aegele Abstract A recent trend in
More informationQuantification of lovastatin in human plasma by LC/ESI/MS/MS using the Agilent 6410 Triple Quadrupole LC/MS system
Quantification of lovastatin in human plasma by LC/ESI/MS/MS using the Agilent 641 Triple Quadrupole LC/MS system Application Note Clinical Research Author Siji Joseph Agilent Technologies Bangalore, India
More informationFolic acid supplementation does not reduce intracellular homocysteine, and may disturb intracellular one-carbon metabolism.
4 Folic acid supplementation does not reduce intracellular homocysteine, and may disturb intracellular one-carbon metabolism. Desirée E.C. Smith a, Jacqueline M. Hornstra b, Robert M. Kok a, Henk J. Blom
More informationCaution: For Laboratory Use. A product for research purposes only. Eu-W1284 Iodoacetamido Chelate & Europium Standard. Product Number: AD0014
TECHNICAL DATA SHEET Lance Caution: For Laboratory Use. A product for research purposes only. Eu-W1284 Iodoacetamido Chelate & Europium Standard Product Number: AD0014 INTRODUCTION: Iodoacetamido-activated
More informationSPE-LC-MS/MS Method for the Determination of Nicotine, Cotinine, and Trans-3-hydroxycotinine in Urine
SPE-LC-MS/MS Method for the Determination of Nicotine, Cotinine, and Trans-3-hydroxycotinine in Urine J. Jones, Thermo Fisher Scientific, Runcorn, Cheshire, UK Application Note 709 Key Words SPE, SOLA
More informationAll stocks and calibration levels were prepared in water: methanol (50:50) v/v to cover range of all steroid concentrations (refer Table 1).
Application LCMS-8040 Simultaneous determination of 11 steroids and Vitamin D2/D3 in human serum using LC/MS/MS - Introduction Quantification of endogenous hormonal steroids and their precursors is essential
More informationO O H. Robert S. Plumb and Paul D. Rainville Waters Corporation, Milford, MA, U.S. INTRODUCTION EXPERIMENTAL. LC /MS conditions
Simplifying Qual/Quan Analysis in Discovery DMPK using UPLC and Xevo TQ MS Robert S. Plumb and Paul D. Rainville Waters Corporation, Milford, MA, U.S. INTRODUCTION The determination of the drug metabolism
More informationMass-Based Purification of Natural Product Impurities Using an Agilent 1260 Infinity II Preparative LC/MSD System
Application Note Food Testing and Agriculture Mass-Based Purification of Natural Product Impurities Using an Agilent 126 Infinity II Preparative LC/MSD System Authors Florian Rieck and Jörg Hippler Agilent
More informationDetection of Low Level of Chloramphenicol in Milk and Honey with MIP SPE and LC-MS-MS
Detection of Low Level of Chloramphenicol in Milk and Honey with MIP SPE and LC-MS-MS Olga Shimelis, An Trinh, and Michael Ye Supelco, Div. of Sigma-Aldrich, Bellefonte, PA T407125 Introduction Molecularly
More informationLC/MS Method for Comprehensive Analysis of Plasma Lipids
Application Note omics LC/MS Method for Comprehensive Analysis of Plasma s Authors Tomas Cajka and Oliver Fiehn West Coast Metabolomics Center, University of California Davis, 451 Health Sciences Drive,
More informationFatty Acid Mass Spectrometry Protocol Updated 10/11/2007 By Daren Stephens
Fatty Acid Mass Spectrometry Protocol Updated 10/11/2007 By Daren Stephens Synopsis: This protocol describes the standard method for extracting and quantifying free fatty acids found in cells and media
More informationLC-MS/MS Method for the Determination of Tenofovir from Plasma
LC-MS/MS Method for the Determination of Tenofovir from Plasma Kimberly Phipps, Thermo Fisher Scientific, Runcorn, Cheshire, UK Application Note 687 Key Words SPE, SOLA CX, Hypersil GOLD, tenofovir Abstract
More informationDevelopment of a Bioanalytical Method for Quantification of Amyloid Beta Peptides in Cerebrospinal Fluid
Development of a Bioanalytical Method for Quantification of Amyloid Beta Peptides in Cerebrospinal Fluid Joanne ( 乔安妮 ) Mather Senior Scientist Waters Corporation Data courtesy of Erin Chambers and Mary
More informationQuantitative Analysis of Underivatized Amino Acids in Plant Matrix by Hydrophilic Interaction Chromatography (HILIC) with LC/MS Detection
Application Note Food Testing, Metabolomics, Agricultural Chemistry, Environmental Quantitative Analysis of Underivatized Amino Acids in Plant Matrix by Hydrophilic Interaction Chromatography (HILIC) with
More informationDetermination of Amantadine Residues in Chicken by LCMS-8040
Liquid Chromatography Mass Spectrometry Determination of Amantadine Residues in Chicken by LCMS-8040 A method for the determination of amantadine in chicken was established using Shimadzu Triple Quadrupole
More informationApplication Note. Introduction. Analysis of Total Aflatoxins in Food by HPLC and UHPLC
Introduction Aflatoxins are a group of mycotoxins produced by microorganisms such as Aspergillus flavus, Aspergillus parasiticus and Aspergillus nomius living in tropical or subtropical regions and have
More informationComprehensive Study of SLE as a Sample. Preparation Tool for Bioanalysis
Comprehensive Study of SLE as a Sample Preparation Tool for Bioanalysis Wan Wang, Warren Chen, Jerry Wang Bonna-Agela Technologies 179 Southern Street, West TEDA, Tianjin, China Abstract A simple, fast,
More informationSupporting Information
Supporting Information Schlosburg et al. 10.1073/pnas.1219159110 SI Materials and Methods: Quantification of Heroin Metabolites Sample Collection. Trunk blood was collected in a 1:1 ratio with acetate
More informationDIRECT EXTRACTION OF BENZODIAZEPINE METABOLITE WITH SUPERCRITICAL FLUID FROM WHOLE BLOOD
DIRECT EXTRACTION OF BENZODIAZEPINE METABOLITE WITH SUPERCRITICAL FLUID FROM WHOLE BLOOD Kenichi TAKAICHI, Shuji SAITOH, Yoshio KUMOOKA, Noriko TSUNODA National Research Institute of Police Science, Chiba,
More informationLANCE Eu-W1024 ITC Chelate & Europium Standard AD0013 Development grade
AD0017P-4 (en) 1 LANCE Eu-W1024 ITC Chelate & Europium Standard AD0013 Development grade INTRODUCTION Fluorescent isothiocyanato-activated (ITC-activated) Eu-W1024 chelate is optimized for labelling proteins
More informationA Novel Solution for Vitamin K₁ and K₂ Analysis in Human Plasma by LC-MS/MS
A Novel Solution for Vitamin K₁ and K₂ Analysis in Human Plasma by LC-MS/MS By Shun-Hsin Liang and Frances Carroll Abstract Vitamin K₁ and K₂ analysis is typically complex and time-consuming because these
More informationDesigner Fentanyls Drugs that kill and how to detect them. Cyclopropylfentanyl
Designer Fentanyls Drugs that kill and how to detect them Cyclopropylfentanyl Science for a safer world The in vitro metabolism of cyclopropylfentanyl Simon Hudson & Charlotte Cutler, Sport and Specialised
More informationCaution: For Laboratory Use. A product for research purposes only. Eu-W1024 ITC Chelate & Europium Standard. Product Number: AD0013
TECHNICAL DATA SHEET Lance Caution: For Laboratory Use. A product for research purposes only. Eu-W1024 ITC Chelate & Europium Standard Product Number: AD0013 INTRODUCTION: Fluorescent isothiocyanato-activated
More informationHomocysteine (plasma, urine, dried blood spots)
Homocysteine (plasma, urine, dried blood spots) 1 Name and description of analyte 1.1 Name of analyte Homocysteine 1.2 Alternative names None 1.3 NLMC code To follow 1.4. Function(s) of analyte Homocysteine
More informationA STUDY OF THE METABOLISM OF THEOBROMINE, THEOPHYLLINE, AND CAFFEINE IN MAN* Previous studies (1, 2) have shown that after the ingestion of caffeine
A STUDY OF THE METABOLISM OF THEOBROMINE, THEOPHYLLINE, AND CAFFEINE IN MAN* BY HERBERT H. CORNISH AND A. A. CHRISTMAN (From the Department of Biological Chemistry, Medical School, University of Michigan,
More informationNeosolaniol. [Methods listed in the Feed Analysis Standards]
Neosolaniol [Methods listed in the Feed Analysis Standards] 1 Simultaneous analysis of mycotoxins by liquid chromatography/ tandem mass spectrometry [Feed Analysis Standards, Chapter 5, Section 1 9.1 ]
More informationPål I. Holm, Per Magne Ueland, * Gry Kvalheim, and Ernst A. Lien. Clinical Chemistry 49: (2003) Nutrition
Clinical Chemistry 49:2 286 294 (2003) Nutrition Determination of Choline, Betaine, and Dimethylglycine in Plasma by a High-Throughput Method Based on Normal-Phase Chromatography Tandem Mass Spectrometry
More informationAnalysis of HMF by HPLC
COST Action 927 Training School Building Skills on the Analysis of Thermal Process Contaminants in Foods 22-26 October 2007, Ankara Analysis of HMF by HPLC Vural Gökmen O O OH Background O COOH O R 2 Carbonyl
More informationUrinary 8-Isoprostane ELISA kit
Urinary 8-Isoprostane ELISA kit Catalog Number: 8isoU Store at -20 C. FOR RESEARCH USE ONLY V.020420 Introduction This competitive ELISA kit is for determination of free and glucronidated 8-isoprostane
More informationNew Method for Determining Cystine in Leukocytes and Fibroblasts
Clinical Chemistry 45:12 2224 2228 (1999) Automation and Analytical Techniques New Method for Determining Cystine in Leukocytes and Fibroblasts Adriana de Graaf-Hess, Frans Trijbels, and Henk Blom * Background:
More informationMS/MS as an LC Detector for the Screening of Drugs and Their Metabolites in Race Horse Urine
Application Note: 346 MS/MS as an LC Detector for the Screening of Drugs and Their Metabolites in Race Horse Urine Gargi Choudhary and Diane Cho, Thermo Fisher Scientific, San Jose, CA Wayne Skinner and
More informationProtein Precipitation for Biological Fluid Samples Using Agilent Captiva EMR Lipid 96-Well Plates
Application Note Clinical Research Protein Precipitation for Biological Fluid Samples Using Agilent Captiva EMR Lipid 96-Well Plates Authors Limian Zhao and Megan Juck Agilent Technologies, Inc. Abstract
More informationRelationship of Total Homocysteine, Cholesterol, Triglyceride in the Serum and Diastolic Blood Pressure of Patients with Myocardial Infarction
Relationship of Total Homocysteine, Cholesterol, Triglyceride in the Serum and Diastolic Blood Pressure of Patients with Myocardial Infarction Durdi Qujeq *1, Laia Hossini 1 and M. Taghi Salehi Omran 2
More informationab Lipid Extraction Kit (Chloroform-Free)
ab211044 Lipid Extraction Kit (Chloroform-Free) Instructions for use: For chloroform-free lipid extraction from plasma, serum, cultured cells and tissues. View kit datasheet: www.abcam.com/ab211044 (use
More informationIodine HPLC Assay. Catalog Number: IOD34-H Tests For Research Use Only. Not for use in diagnostic procedures.
Package Insert Iodine HPLC Assay 100 Tests For Research Use Only. Not for use in diagnostic procedures. v. 1.0 Eagle Biosciences, Inc. 20A Northwest Blvd., Suite 112, Nashua, NH 03063 Phone: 866-419-2019
More informationA Comprehensive Screening of Illicit and Pain Management Drugs from Whole Blood Using SPE and LC/MS/MS
A Comprehensive Screening of Illicit and Pain Management Drugs from Whole Blood Using SPE and LC/MS/MS Introduction Drug analysis from whole blood is gaining popularity due to a more complete measurement
More informationDetermination and pharmacokinetics of manidipine in human plasma by HPLC/ESIMS
BIOMEDICAL CHROMATOGRAPHY Biomed. Chromatogr. 21: 836 840 (2007) Published 836 online ORIGINAL 12 April RESEARCH 2007 in Wiley InterScience ORIGINAL RESEARCH (www.interscience.wiley.com).827 Determination
More informationPAF Acetylhydrolase Assay Kit
PAF Acetylhydrolase Assay Kit Catalog Number KA1354 96 assays Version: 04 Intended for research use only www.abnova.com Table of Contents Introduction... 3 Background... 3 Principle of the Assay... 3 General
More informationDELFIA Tb-N1 DTA Chelate & Terbium Standard
AD0029P-1 (en) 1 DELFIA Tb-N1 DTA Chelate & AD0012 Terbium Standard For Research Use Only INTRODUCTION DELFIA Tb-N1 DTA Chelate is optimized for the terbium labeling of proteins and peptides for use in
More informationSCIEX Vitamin D 200M Assay for the Topaz System
The First FDA-Cleared LC-MS/MS Assay for Vitamin D SCIEX Vitamin D 200M Assay for the Topaz System The first FDA-cleared LC-MS/MS assay for Vitamin D Vitamin D is an important building block for human
More informationMeasuring Phytosterols in Health Supplements by LC/MS. Marcus Miller and William Schnute Thermo Fisher Scientific, San Jose, CA, USA
Measuring Phytosterols in Health Supplements by LC/MS Marcus Miller and William Schnute Thermo Fisher Scientific, San Jose, CA, USA Overview Purpose: Develop a method for the extraction of phytosterols
More informationAnalytical Method for 2, 4, 5-T (Targeted to Agricultural, Animal and Fishery Products)
Analytical Method for 2, 4, 5-T (Targeted to Agricultural, Animal and Fishery Products) The target compound to be determined is 2, 4, 5-T. 1. Instrument Liquid Chromatograph-tandem mass spectrometer (LC-MS/MS)
More informationDetermination of red blood cell fatty acid profiles in clinical research
Application Note Clinical Research Determination of red blood cell fatty acid profiles in clinical research Chemical ionization gas chromatography tandem mass spectrometry Authors Yvonne Schober 1, Hans
More informationDetermination of Aflatoxins in Food by LC/MS/MS. Application. Authors. Abstract. Experimental. Introduction. Food Safety
Determination of Aflatoxins in Food by LC/MS/MS Application Food Safety Authors Masahiko Takino Agilent Technologies 9-1 Takakura-Cho Hachiouji-Shi, Tokyo Japan Toshitsugu Tanaka Kobe Institute of Health
More informationDetection, Confirmation, and Quantification of Chloramphenicol in Honey, Shrimp and Chicken Using the Agilent 6410 LC/MS Triple Quadrupole
Detection, Confirmation, and Quantification of Chloramphenicol in Honey, Shrimp and Chicken Using the Agilent LC/MS Triple Quadrupole Application Food Safety Authors Yanyan Fang Agilent Technologies (Shanghai),
More informationTECHNICAL BULLETIN. Sialic Acid Quantitation Kit. Catalog Number SIALICQ Storage Temperature 2 8 C
Sialic Acid Quantitation Kit Catalog Number SIALICQ Storage Temperature 2 8 C TECHNICAL BULLETIN Product Description The Sialic Acid Quantitation Kit provides a rapid and accurate determination of total
More informationab Lipid Peroxidation (MDA) Assay kit (Colorimetric/ Fluorometric)
Version 10b Last updated 19 December 2018 ab118970 Lipid Peroxidation (MDA) Assay kit (Colorimetric/ Fluorometric) For the measurement of Lipid Peroxidation in plasma, cell culture and tissue extracts.
More informationRemoval of Triton X-100 from Plasma Samples Using Mixed-Mode Solid Phase Extraction (SPE)
Removal of Triton X- from Plasma Samples Using Mixed-Mode Solid Phase Extraction (SPE) Jonathan P. Danaceau, Erin Chambers, and Kenneth J. Fountain Waters Corporation, 34 Maple Street, Milford, MA USA
More informationAntoine Bouchoux, Pierre-Emerson Cayemitte, Julien Jardin, Geneviève Gésan-Guiziou, and Bernard Cabane
Biophysical Journal, Volume 96 Supplementary Material Casein Micelle Dispersions under Osmotic Stress Antoine Bouchoux, Pierre-Emerson Cayemitte, Julien Jardin, Geneviève Gésan-Guiziou, and Bernard Cabane
More informationCauses of Hyperhomocysteinemia in Patients With Chronic Kidney Diseases
Causes of Hyperhomocysteinemia in Patients With Chronic Kidney Diseases Giacomo Garibotto, Antonella Sofia, Alessandro Valli, Alice Tarroni, Massimiliano Di Martino, Valeria Cappelli, Francesca Aloisi,
More informationCobalamin deficiency with and without neurologic abnormalities: differences in homocysteine and methionine metabolism
RED CELLS Cobalamin deficiency with and without neurologic abnormalities: differences in homocysteine and methionine metabolism Ralph Carmel, Stepan Melnyk, and S. Jill James The unknown biochemical basis
More informationSurviving Matrix Effects Experiments. Grace van der Gugten St. Paul s Hospital, Vancouver, BC, Canada
Surviving Matrix Effects Experiments Grace van der Gugten St. Paul s Hospital, Vancouver, BC, Canada gvandergugten@providencehealth.bc.ca Outline What are matrix effects Post Column Infusion Phospholipid
More informationDELFIA Tb-DTPA ITC Chelate & Terbium Standard
AD0035P-2 (en) 1 DELFIA Tb-DTPA ITC Chelate & AD0029 Terbium Standard For Research Use Only INTRODUCTION DELFIA Tb-DTPA ITC Chelate is optimized for the terbium labelling of proteins and peptides for use
More informationSupporting information
Supporting information Figure legends Supplementary Table 1. Specific product ions obtained from fragmentation of lithium adducts in the positive ion mode comparing the different positional isomers of
More informationAnalysis of Testosterone, Androstenedione, and Dehydroepiandrosterone Sulfate in Serum for Clinical Research
Analysis of Testosterone, Androstenedione, and Dehydroepiandrosterone Sulfate in Serum for Clinical Research Dominic Foley, Michelle Wills, and Lisa Calton Waters Corporation, Wilmslow, UK APPLICATION
More informationManual (Second edition)
Reagent for RNA Extraction ISOGENⅡ Manual (Second edition) Code No. 311-07361 Code No. 317-07363 NIPPON GENE CO., LTD. Table of contents I Product description 1 II Product content 1 III Storage 1 IV Precautions
More informationSupporting Information for:
Supporting Information for: Methylerythritol Cyclodiphosphate (MEcPP) in Deoxyxylulose Phosphate Pathway: Synthesis from an Epoxide and Mechanisms Youli Xiao, a Rodney L. Nyland II, b Caren L. Freel Meyers
More informationFor Research Use Only Ver
INSTRUCTION MANUAL Quick-cfDNA Serum & Plasma Kit Catalog No. D4076 Highlights High-quality DNA, including cell-free, is easily and robustly purified from up to 10 ml of serum/plasma, up to 1 ml amniotic
More informationLC/MS/MS Separation of Cholesterol and Related Sterols in Plasma on an Agilent InfinityLab Poroshell 120 EC C18 Column
Application Note Clinical Research LC/MS/MS Separation of Cholesterol and Related Sterols in Plasma on an Agilent InfinityLab Poroshell EC C8 Column Authors Rongjie Fu and Zhiming Zhang Agilent Technologies
More informationMS/MS APPROACHES TO CLINICAL TESTING FOR INBORN ERRORS OF METABOLISM
MS/MS APPROACHES TO CLINICAL TESTING FOR INBORN ERRORS OF METABOLISM Tina M. Cowan, PhD Director, Clinical Biochemical Genetics Laboratory Stanford University Medical Center Presented at the 2011 Stanford
More informationBabyBio IMAC columns DATA SHEET DS
BabyBio IMAC columns DATA SHEET DS 45 655 010 BabyBio columns for Immobilized Metal Ion Affinity Chromatography (IMAC) are ready-to-use for quick and easy purification of polyhistidine-tagged (His-tagged)
More informationab65336 Triglyceride Quantification Assay Kit (Colorimetric/ Fluorometric)
Version 10 Last updated 19 December 2017 ab65336 Triglyceride Quantification Assay Kit (Colorimetric/ Fluorometric) For the measurement of triglycerides in various samples. This product is for research
More informationKey Words: Brassica oleraceae, glucosinolate, liquid chromatography mass spectrometry, FNH-I-003
IDENTIFICATION OF MAJOR GLUCOSINOLATES IN BROCCOLI (Brassica oleracea var. italica) BY LIQUID CHROMATOGRAPHY MASS SPECTROMETRY (LC-MS) AND DETERMINATION OF ANTICANCER PROPERTIES OF BROCCOLI EXTRACTS Carlos
More informationDELFIA Eu-DTPA ITC Chelate & Europium Standard
AD0026P-3 (en) 1 DELFIA Eu-DTPA ITC Chelate & AD0021 Europium Standard For Research Use Only INTRODUCTION DELFIA Eu-DTPA ITC Chelate is optimized for the europium labelling of proteins and peptides for
More informationCore E Analysis of Neutral Lipids from Human Plasma June 4, 2010 Thomas J. Leiker and Robert M. Barkley
Core E Analysis of Neutral Lipids from Human Plasma June 4, 2010 Thomas J. Leiker and Robert M. Barkley This protocol describes the extraction and direct measurement of cholesterol esters (CEs) and triacylglycerols
More informationE.Z.N.A. SQ Blood DNA Kit II. Table of Contents
E.Z.N.A. SQ Blood DNA Kit II Table of Contents Introduction and Overview...2 Kit Contents/Storage and Stability...3 Blood Storage and DNA Yield...4 Preparing Reagents...5 100-500 μl Whole Blood Protocol...6
More informationUltrafast Analysis of Benzodiazepines in Urine by the Agilent RapidFire High-Throughput Triple Quadrupole Mass Spectrometry System
Ultrafast Analysis of Benzodiazepines in Urine by the Agilent RapidFire High-Throughput Triple Quadrupole Mass Spectrometry System Application Note Forensic Toxicology Authors Nikunj R. Parikh, Michelle
More informationQuantitative Analysis of Vit D Metabolites in Human Plasma using Exactive System
Quantitative Analysis of Vit D Metabolites in Human Plasma using Exactive System Marta Kozak Clinical Research Applications Group Thermo Fisher Scientific San Jose CA Clinical Research use only, Not for
More informationAnalysis of Acrylamide in French Fries using Agilent Bond Elut QuEChERS AOAC kit and LC/MS/MS
Analysis of Acrylamide in French Fries using Agilent Bond Elut QuEChERS AOAC kit and LC/MS/MS Food Application Author Fadwa Al-Taher Institute for Food Safety and Health Illinois Institute of Technology
More informationShuguang Li, Jason Anspach, Sky Countryman, and Erica Pike Phenomenex, Inc., 411 Madrid Ave., Torrance, CA USA PO _W
Simple, Fast and Accurate Quantitation of Human Plasma Vitamins and Their Metabolites by Protein Precipitation Combined with Columns Using HPLC-UV, HPLC-FLD or LC/MS/MS Shuguang Li, Jason Anspach, Sky
More informationAnalysis of formaldehyde in blood of rats during and after inhalation exposure
Analysis of formaldehyde in blood of rats during and after inhalation exposure Sponsor: Research laboratory: P.O. Box 844 3700 AV Zeist The Netherlands Presenter: Dr. A.J. Kleinnijenhuis T +31 88 866 28
More informationLab Guide 2019 Metabolic Section Lab Guide
Lab Guide 2019 Metabolic Section Lab Guide Quantitative Amino acids Plasma Plasma. Container/Tube: Preferred EDTA, Place immediately in ice. Acceptable: lithium heparin, sodium heparin. Patient preparation:
More informationProfiling of Endogenous Metabolites Using Time-of-Flight LC/MS with Ion Pair Reverse Phase Chromatography
Profiling of Endogenous Metabolites Using Time-of-Flight LC/MS with Ion Pair Reverse Phase Chromatography Application Note Metabolomics Author Yuqin Dai Agilent Technologies, Inc. 31 Stevens Creek Blvd,
More informationChemical Metrology for Human Health Assessment
Chemical Metrology for Human Health Assessment Metrology and Physical Constants International School of Physics Enrico Fermi Stephen A. Wise Analytical Chemistry Division Material Measurement Laboratory
More informationAmphetamines, Phentermine, and Designer Stimulant Quantitation Using an Agilent 6430 LC/MS/MS
Amphetamines, Phentermine, and Designer Stimulant Quantitation Using an Agilent 643 LC/MS/MS Application Note Forensics Authors Jason Hudson, Ph.D., James Hutchings, Ph.D., and Rebecca Wagner, Ph.D. Virginia
More informationAnalysis of Choline and its Metabolites on the Finnigan LTQ
Analysis of Choline and its Metabolites on the Finnigan LTQ Gargi Choudhary Diane Cho Thermo Electron, San Jose, CA Abstracted from a poster presented at Montreux 3 LC/MS Symposium, with co-authors: Brad
More informationPapers in Press. First published August 25, 2005 as doi: /clinchem
Papers in Press. First published August 25, 2005 as doi:10.1373/clinchem.2005.053835 Clinical Chemistry 51:11 000 000 (2005) Automation and Analytical Techniques Automated Assay for the Determination of
More informationCarnitine / Acylcarnitines Dried Blood Spots LC-MS/MS Analysis Kit User Manual
Page 1 / 14 Carnitine / Acylcarnitines Dried Blood Spots LC-MS/MS Analysis Kit User Manual ZV-3051-0200-15 200 Page 2 / 14 Table of Contents 1. INTENDED USE... 3 2. SUMMARY AND EXPLANATION... 3 3. TEST
More information